Physician profile
David Michael Stepien
NPI 1194103598
$1,760.36
in general payments reported to CMS, 2019-2025
8 companies · $600 in 2025
The $600 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $149 · 2023: $509 · 2024: $502 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,492 · Travel and Lodging: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,491.99 |
| Travel and Lodging | $118.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $716.02 | 2022-2025 | Natrelle Saline-Filled Breast Implants |
| Mentor Worldwide LLC | $237.47 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $218.95 | 2023-2025 | |
| Integra Lifesciences Corporation | $137.97 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acera Surgical, INC. | $133.50 | 2024 | Restrata Wound Matrix |
| Rti Surgical, INC | $125.93 | 2023 | |
| Stryker Corporation | $115.52 | 2024 | Vsp System, Vsp Cranial |
| Motiva USA, LLC | $75.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Stepien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.